Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001831283-22-000014
Filing Date
2022-03-31
Accepted
2022-03-31 08:55:59
Documents
111
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adr-20211231.htm   iXBRL 10-K 3188476
2 EX-4.15 exhibit415-descriptionofse.htm EX-4.15 106538
3 EX-10.12 exhibit1012-qedxlianbiolic.htm EX-10.12 66184
4 EX-10.20 exhibit1020-pfizerassignme.htm EX-10.20 28633
5 EX-10.37 exhibit1037-amendedandrest.htm EX-10.37 155128
6 EX-10.41 exhibit1041-formofnonxperf.htm EX-10.41 31635
7 EX-10.42 exhibit1042-formofperforma.htm EX-10.42 34336
8 EX-10.43 exhibit1043-formofnonxperf.htm EX-10.43 31989
9 EX-10.44 exhibit1044-formofperforma.htm EX-10.44 38408
10 EX-21.1 exhibit211subsidiaries.htm EX-21.1 10724
11 EX-23.1 exhibit231-consentofkpmgllp.htm EX-23.1 2170
12 EX-31.1 exhibit311-certificationof.htm EX-31.1 16624
13 EX-31.2 exhibit312-certificationof.htm EX-31.2 16636
14 EX-32.1 exhibit321-certificationof.htm EX-32.1 5337
15 EX-32.2 exhibit322-certificationof.htm EX-32.2 5349
21 adr-20211231_g1.jpg GRAPHIC 218718
22 adr-20211231_g10.jpg GRAPHIC 247622
23 adr-20211231_g11.jpg GRAPHIC 269463
24 adr-20211231_g12.jpg GRAPHIC 119734
25 adr-20211231_g13.jpg GRAPHIC 270755
26 adr-20211231_g14.jpg GRAPHIC 364058
27 adr-20211231_g15.jpg GRAPHIC 662193
28 adr-20211231_g16.jpg GRAPHIC 327104
29 adr-20211231_g17.jpg GRAPHIC 456644
30 adr-20211231_g2.jpg GRAPHIC 138246
31 adr-20211231_g3.jpg GRAPHIC 668930
32 adr-20211231_g4.jpg GRAPHIC 66878
33 adr-20211231_g5.jpg GRAPHIC 14535
34 adr-20211231_g6.jpg GRAPHIC 50156
35 adr-20211231_g7.jpg GRAPHIC 579058
36 adr-20211231_g8.jpg GRAPHIC 44923
37 adr-20211231_g9.jpg GRAPHIC 96857
  Complete submission text file 0001831283-22-000014.txt   22949529

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adr-20211231.xsd EX-101.SCH 57271
17 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adr-20211231_cal.xml EX-101.CAL 90919
18 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adr-20211231_def.xml EX-101.DEF 334650
19 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adr-20211231_lab.xml EX-101.LAB 753784
20 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adr-20211231_pre.xml EX-101.PRE 527681
105 EXTRACTED XBRL INSTANCE DOCUMENT adr-20211231_htm.xml XML 1662680
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40947 | Film No.: 22789333
SIC: 2834 Pharmaceutical Preparations